Universal Time: 13:34  |  Local Time: 13:34 (3h GMT)
Select your timezone:

Abstract Session
Novel therapeutics and immunosuppression strategies 1

Tuesday September 24, 2024 | 13:40 to 15:10
Room: Beylerbeyi 2
Track: N/A

Video is available - Log in to view. You must be registered to the event to view content

Presentations

Dr. Moritz Muckenhuber, Austria Oral
Interleukin-6 blockade prevents costimulation blockade-resistant allograft rejection by promoting intragraft regulation

Dr. Hikaru Aoki, Japan Oral
Adverse effects of graft congestion and ameliorative effects of hepatocyte growth factor after liver transplantation in rats

Dr. Fatma Dogan, United States Oral
Immunoisolation and islet survival in the absence of systemic immune suppression enabled by co-delivery of CXCL12 and FasL containing microgels in allo-islet transplanted diabetic mice

Ms. Franco Citterio, Italy Oral
Long term results of de novo kidney transplant recipients treated with the combination of low dose Tacrolimus and Everolimus.

Dr. Giuseppe Pettinato, United States Oral
Alpha-1 antitrypsin-loaded nanoparticles improve transplantation outcomes in an acute liver failure rat model

Dr. Feng Wang, People's Republic of China Oral
Systemic treatment with a novel form of FasL induces tolerance to cardiac allograft in mice

Dr. Jinren Zhou, People's Republic of China Oral
Lactate remodulates the OXPHOS of Tregs by inducing N-glycosylation in mitochondria via transcription and translocation of MGAT1

Ms. Rachel Todd, United States Oral
Normothermic Machine Perfusion of Explanted Livers: Pilot of a Novel Translational Model for End-Stage Liver Disease

Dr. Yu Li, People's Republic of China Oral
The mechanism research of intrahepatic glutamine metabolism promoting the differentiation of GARP Tregs to reshape the immune tolerance microenvironment post liver transplantation

The WebApp is sponsored by